Transcriptomics

Dataset Information

4

MicroRNA profiling by array of mouse lung from individuals sensitised with chicken egg OVA and then challenged with aerosolised OVA


ABSTRACT: specific pathogen-free female BALB/c mice aged 7-8 weeks (Animal Resources Centre, Perth, Western Australia) were systemically sensitised by intraperitoneal injection of 50 µg of alum-precipitated chicken egg OVA (Grade V, ?98% pure, Sigma Australia) 21 and 7 days before inhalational challenge, then exposed to aerosolised OVA in a whole body inhalation exposure chamber (Unifab Corporation, Kalamazoo, MI). Chronic low-level challenge involved exposure to ?3 mg/m3 aerosolised OVA for 30 minutes/day on 3 days/week for up to 6 weeks. Particle concentration within the chamber was continuously monitored using a DustTrak 8520 instrument (TSI, St Paul, MN). All experimental procedures complied with the requirements of the Animal Care and Ethics Committee of the University of New South Wales (reference numbers: 06/119B and 08/09B). Mice were sacrificed after 1,2,4 and 6 weeks of OVA exposure. Control groups included naïve mice and mice that were not sensitised but were challenged for 6 weeks with aerosolised OVA.

ORGANISM(S): Mus musculus  

SUBMITTER: Adam Collison  

PROVIDER: E-MEXP-3118 | ArrayExpress | 2011-06-10

REPOSITORIES: ArrayExpress

altmetric image

Publications

Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target.

Collison Adam A   Herbert Cristan C   Siegle Jessica S JS   Mattes Joerg J   Foster Paul S PS   Kumar Rakesh K RK  

BMC pulmonary medicine 20110523


BACKGROUND: The role of microRNAs (miRNAs) in regulating gene expression is currently an area of intense interest. Relatively little is known, however, about the role of miRNAs in inflammatory and immunologically-driven disorders. In a mouse model, we have previously shown that miRNAs are potentially important therapeutic targets in allergic asthma, because inhibition of miR-126, one of a small subset of miRNAs upregulated in the airway wall, effectively suppressed Th2-driven airway inflammation  ...[more]

Similar Datasets

2009-10-01 | E-MEXP-2081 | ArrayExpress
2007-08-01 | E-MEXP-1053 | ArrayExpress
2007-01-30 | E-TABM-191 | ArrayExpress
2008-10-26 | E-TABM-364 | ArrayExpress
2005-01-01 | E-FPMI-2 | ArrayExpress
2005-12-31 | E-MEXP-496 | ArrayExpress
2015-11-02 | E-MTAB-309 | ExpressionAtlas
2006-06-01 | E-MEXP-507 | ArrayExpress
2005-01-01 | E-FPMI-3 | ArrayExpress
2008-01-11 | E-GEOD-10145 | ArrayExpress